Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3176-3181

  Mills, Katherine T ^a   Kobori, Hiroyuki ^b   Hamm, Lotuce Lee ^b   Alper, Arnold Brent ^b   Khan, Islam Enver ^b   Rahman, Mahfuz ^b   Navar, Luis Gabriel ^b   Liu, Yanxi ^a   Browne, Grace M ^a   Batuman, Vecihi ^b   He, Jiang ^a,b   Chen, Jing ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

albuminuria; angiotensinogen; chronic kidney disease; estimated glomerular filtration rate; reninangiotensin system

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; ANGIOTENSINOGEN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 84864586691     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs011     Document Type: Article

References (27)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
3. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
4. Chronic Kidney Disease Prognosis Consortium. Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
5. Remuzzi G, Perico N, Macia M et al. The role of renin- angiotensinaldosterone system in the progression of chronic kidney disease. Kidney Int 2005; 68(Suppl): S57-S65.
6. Ruster C, Wolf G Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 2006; 17: 2985-2991.
7. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857-1863.
8. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
9. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
10. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
11. Kobori H, Nangaku M, Navar LG et al. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
12. Mezzano S, Droguett A, Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003; 86: S64-S70.
13. Park S, Bivona BJ, Kobori H et al. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 2010; 298: F37-F48.
14. Huang XR, Chen WY, Truong LD et al. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 2003; 14: 1738-1747.
15. Kobori H, Harrison-Bernard LM, Navar LG Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002; 61: 579-585.
16. Kobori H, Nishiyama A, Harrison-Bernard LM et al. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003; 41: 42-49.
17. Kobori H, Alper AB, Jr, Shenava R et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 2009; 53: 344-350.
18. Kobori H, Ohashi N, Katsurada A et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2008; 2: 349-354.
19. Yamamoto T, Nakagawa T, Suzuki H et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 1558-1565.
20. Kim SM, Jang HR, Lee YJ et al. Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease. Clin Nephrol 2011; 76: 117-123.
21. Perloff D, Grim C, Flack J et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
22. Verbraecken J, Van de Heyning P, De Backer Wet al. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 2006; 55: 515-524.
23. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
24. Katsurada A, Hagiwara Y, Miyashita K et al. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol 2007; 293: F956-F960.
25. Kobori H, Ozawa Y, Suzaki Y et al. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005; 16: 2073-2080.
26. Kobori H, Ozawa Y, Suzaki Y et al. Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens 2006; 19: 541-550.
27. Siragy HM, Carey RM. Role of the intrarenal renin-angiotensinaldosterone system in chronic kidney disease. Am J Nephrol 2010; 31: 541-550